Yeah, 2 x 600 patient trials doesn't sound uber expensive, particular for a company of Teva's size. So, financially, they'd be saving lunch & dinner money if they decided to quit. On the other hand, they stand to gain handsomely by the relatively modest investment.
Having said all that, like other posters have said, sometimes companies, particularly large companies, do inexplicable things....
I'm placing a 15.75%* chance of Teva walking.
* based on a complex matrix of calculations
Yeah, 2 x 600 patient trials doesn't sound uber expensive,...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |